...

首页> 外文期刊>Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver >Direct antiviral agents for treatment-naive patients with genotype 1 hepatitis C: A statistical model for comparing outcomes between real world and clinical trials

【24h】

Direct antiviral agents for treatment-naive patients with genotype 1 hepatitis C: A statistical model for comparing outcomes between real world and clinical trials

机译：直接治疗初治的基因型1型丙型肝炎患者的直接抗病毒药物：用于比较现实世界和临床试验结果的统计模型

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 》 |2015年第11期| 共2页
作者
Messori Andrea; Brunetto Maurizia R.; De Luca Andrea; Zignego Anna Linda;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. Direct antiviral agents for treatment-naive patients with genotype 1 hepatitis C: A statistical model for comparing outcomes between real world and clinical trials [J] . Messori Andrea, Brunetto Maurizia R., De Luca Andrea, Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver . 2015 ,第11期

机译：直接治疗初治的基因型1型丙型肝炎患者的直接抗病毒药物：用于比较现实世界和临床试验结果的统计模型
2. Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia [J] . Ligita Jancoriene, Katazyna Polubenko, Edita Kazenaite, Hepatitis Monthly . 2018 ,第1期

机译：直接作用抗病毒药物Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir联合或不联合利巴韦林在C型肝炎病毒（HCV）基因型1中感染的未接受过治疗或有治疗经验的患者是否患有肝硬化：立陶宛和拉脱维亚的真实生活
3. Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment [J] . Tzu-Sheng Cheng, Po-Cheng Liang, Chung-Feng Huang, Kaohsiung Journal of Medical Sciences . 2021 ,第4期

机译：完成治疗后基因型-2感染慢性丙型肝炎患者直接作用抗病毒剂的实际效力
4. Prediction of liver cancer development risk in genotype 4 hepatitis C patients using knowledge discovery modeling [C] . Tasneem A. Gameel, Sherine Rady, Khaled A. El-Bahnasy, IEEE International Conference on Intelligent Computing and Information Systems . 2017

机译：使用知识发现模型预测基因4型丙型肝炎患者的肝癌发展风险
5. Clinical and economic outcomes of direct-acting antivirals for chronic hepatitis C infection in Oklahoma Medicaid. [D] . Pham, Timothy Tung. 2016

机译：直接作用抗病毒药在俄克拉荷马州医疗补助中的慢性丙型肝炎感染的临床和经济结果。
6. Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients [O] . Zhanyi Li, Ying Liu, Ying Zhang, 2006

机译：丙型肝炎病毒基因型6a感染患者中丙型肝炎病毒直接作用抗病毒药物的天然耐药性变异体
7. Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia [O] . Ligita Jancoriene, Katazyna Polubenko, Edita Kazenaite, 2018

机译：直接作用抗病毒药虫/ paritabrevir / ritonavir + dasabuvir在丙啶病毒（hcv）基因虫中（hcv）基因型1-感染的治疗 - 幼稚或治疗 - 经验丰富的患者或没有肝硬化的患者：立陶宛和拉脱维亚的现实生活经验

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号